ISTA Pharmaceuticals Announces Positive Results for Xibrom™ Once-Daily
Links shared publicly online about this topic.
- 1,785total visits
ISTA Pharmaceuticals Announces Positive Results for Xibrom™ Once-Daily
ISTA Pharmaceuticals, Inc. has announced positive Phase 3 results from a confirmatory clinical trial with Xibrom™ (bromfenac ophthalmic solution) 0.09% QD in the treatment of ocular inflammation and pain after cataract surgery.
View full resource at eyedocnews.com
Tags: Pain, Cataract, Pharma, Clinical Trial, Surgery
Most Recently Shared on August 30, 2009 at 10:37 pm By:
Discuss: ISTA Pharmaceuticals Announces Positive Results for Xibrom: By Dr. Dominique Walton BrooksISTA .. http://bit.ly/14srOS
Ista announces positive preliminary results from phase 3 trial of once-daily bromfenac
osnsupersite.com — “IRVINE, Calif. — Ista Pharmaceuticals has announced positive preliminary phase 3 results from the company's confirmatory clinical trial of a” View full resource at osnsupersite.com
Most Recently Shared on August 26, 2009 at 3:25 pm By:
Ista announces positive preliminary results from phase 3 trial of once-daily bromfenac: http://ow.ly/lplZ
Advertisement
